Inventor · disambiguated record
Xiaoling Zheng
Also filed as: ZHENG XIAOLING
13 granted patents·13 pending applications·294 citations·filing 1999–2023
91Inventor score
Files withNEWGEN THERAPEUTICS INC7COCRYSTAL DISCOVERY INC3HONGENE BIOTECH CORP3SHEN WANG3LIFESCAN INC2
Top patents by PatentIndex Score
26 records- 0196US6939685B2Stabilized tetrazolium phenazine reagent compositions and methods for using the sameLIFESCAN INC·Filed 2001·Granted Sep 6, 2005·112 cites·12 claims
- 0296US6218571B18-(anilino)-1-naphthalenesulfonate analogsLIFESCAN INC·Filed 1999·Granted Apr 17, 2001·151 cites·38 claims
- 0393US11649260B2Functionalized N-acetylgalactosamine nucleosidesHONGENE BIOTECH CORP·Filed 2022·Granted May 16, 2023·3 cites·23 claims
- 0492US11692001B2Functionalized n-acetylgalactosamine analogsHONGENE BIOTECH CORP·Filed 2022·Granted Jul 4, 2023·3 cites·31 claims
- 0591US8771665B2Inhibitors of hepatitis C virus polymeraseLEE SAM S K·Filed 2011·Granted Jul 8, 2014·13 cites·13 claims
- 0690US11884691B2Functionalized n-acetylgalactosamine analogsHONGENE BIOTECH CORP·Filed 2023·Granted Jan 30, 2024·1 cites·27 claims
- 0781US9090588B2Alkyne substituted quinazoline compound and methods of useSHEN WANG·Filed 2012·Granted Jul 28, 2015·4 cites·27 claims
- 0878US11248013B2Tricyclic inhibitors of poly(ADP-ribose)polymeraseRAKOVINA THERAPEUTICS INC·Filed 2019·Granted Feb 15, 2022·1 cites·23 claims
- 0973US9707215B2Inhibitors of hepatitis C virus polymeraseCOCRYSTAL DISCOVERY INC·Filed 2013·Granted Jul 18, 2017·3 cites·10 claims
- 1072US2023027257A1Tricyclic inhibitors of poly(adp-ribose)polymeraseRAKOVINA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1169US9187459B2Quinazoline-7-ether compounds and methods of useSHEN WANG·Filed 2012·Granted Nov 17, 2015·2 cites·29 claims
- 1268US8987284B2Phosphorus containing quinazoline compounds and methods of useSHEN WANG·Filed 2010·Granted Mar 24, 2015·1 cites·24 claims
- 1365US2009253648A1Tricyclic-Nucleoside Compounds for Treating Viral InfectionsSMITHKLINE BEECHAM CORP·Filed 2009·Application pending·0 cites
- 1463US11524956B2Alkyne substituted quinazoline compound and methods of useNEWGEN THERAPEUTICS INC·Filed 2020·Granted Dec 13, 2022·0 cites·55 claims
- 1557US2019382382A1Alkyne substituted quinazoline compound and methods of useNEWGEN THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1655US2014322165A1Inhibitors of hepatitis c virus polymeraseCOCRYSTAL DISCOVERY INC·Filed 2014·Application pending·0 cites
- 1753US2018093975A1Alkyne substituted quinazoline compound and methods of useNEWGEN THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1852US2018094010A1Tricyclic inhibitors of poly(adp-ribose)polymeraseNEWGEN THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1951US2014221314A1Tricyclic inhibitors of poly(adp-ribose)polymeraseNEWGEN THERAPEUTICS INC·Filed 2012·Application pending·0 cites
- 2051US2009197856A1Antiviral compoundsNOVARTIS AG·Filed 2008·Application pending·0 cites
- 2150US2009062223A1Amino tricyclic-nucleoside compounds, compositions, and methods of useGENELABS TECH INC·Filed 2008·Application pending·0 cites
- 2249US2009048189A1Tricyclic-nucleoside compounds for treating viral infectionsGILEAD SCIENCES INC·Filed 2007·Application pending·0 cites
- 2349US2017057984A1Tricyclic inhibitors of poly(adp-ribose)polymeraseNEWGEN THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2447US2003170772A1Stabilized tetrazolium-phenazine reagent compositions and methods for using the sameFiled 2003·Application pending·0 cites
- 2547US2016031860A1Alkyne substituted quinazoline compound and methods of useNEWGEN THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2646US10426762B2Inhibitors of hepatitis C virus polymeraseCOCRYSTAL DISCOVERY INC·Filed 2017·Granted Oct 1, 2019·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Xiaoling Zheng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →